医学
心力衰竭
糖尿病
内科学
心脏病学
重症监护医学
内分泌学
作者
Deepak L. Bhatt,Michael Szarek,Philippe Gabríel Steg,Christopher P. Cannon,Lawrence A. Leiter,Darren K. McGuire,Julia B. Lewis,Matthew C. Riddle,Adriaan A. Voors,Marco Metra,Lars H. Lund,Michel Komajda,Jeffrey M. Testani,Christopher S. Wilcox,Piotr Ponikowski,Renato D. Lópes,Subodh Verma,Pablo Lapuerta,Bertram Pitt
标识
DOI:10.1056/nejmoa2030183
摘要
In patients with diabetes and recent worsening heart failure, sotagliflozin therapy, initiated before or shortly after discharge, resulted in a significantly lower total number of deaths from cardiovascular causes and hospitalizations and urgent visits for heart failure than placebo. (Funded by Sanofi and Lexicon Pharmaceuticals; SOLOIST-WHF ClinicalTrials.gov number, NCT03521934.).
科研通智能强力驱动
Strongly Powered by AbleSci AI